TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: blood pressure improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: microleakage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of educational intervention on pain management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality Indicators (QIs) development methodology consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of quality of care based on recommended QIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate of arrhythmia to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: inflammation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular allergic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Obstructions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in periodontal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of all-cause total joint replacements
Endpoint domain: Adverse events/effects
Primary endpoint: In-stent late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binary in-stent restenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target lesion revascularization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accumulation of collagen in healing wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of wheezing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endoscopist's and patients' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: unplanned catheter removal rate
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of mechanical phlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of venous thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: risk of acute rejection (AR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: new onset diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time of onset of botulinum toxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficacy of botulinum toxin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duodenal ulcer healed at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physical function improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct incisions made
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk-adjusted absolute mortality
Endpoint domain: Mortality/survival
Primary endpoint: Score on domestic violence checklist items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of seizure-free patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severely prolonged QTcA as a predictor of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Higher hospitalization rates associated with prolonged QTcA
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Nasal cavity volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between PMS index and headache index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-hospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in health state or management of condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prostatitis-related sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostatitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAS score (anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Return of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isokinetic plantar flexion peak torque deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: isometric plantar flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: markedly and cured effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of CC16 level after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of episodes prevented during overdrive period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MCA blood flow redistribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence of cesarean delivery
Endpoint domain: Adverse events/effects
Primary endpoint: Need for neonatal admission
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of platelet count to 100,000 per cubic millimeter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Median time to recovery of platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dementia care competence of nurses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative emotional responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of progression of PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of psychotic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerability of Brivaracetam
Endpoint domain: Adverse events/effects
Primary endpoint: Nakata index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ACR 50% improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biocompatibility of membranes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superior psychomotor skills in a live porcine model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: superior nontechnical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: school functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of hands-off time during CPR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median shade change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global improvement of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mtDNA copy number (mtDNAcn)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECLAM index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum CH50
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: anti‐dsDNA antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prescription of fluoroquinolones
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity for HGD/EC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate erectile response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to practice safe sex
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual risk reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy for sexual discussion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-thrombotic syndrome (PTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of intubation in the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in the number of painful days per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of analgesic tablets per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients becoming pain free
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annual wear rate of the composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean 8 hour diurnal IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triglyceride reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sense of ownership in rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of anterior chamber flare after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of postoperative macular edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective tolerability values
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bowel preparation for right colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working hours lost
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major drusen reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of laser‐induced lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean area of RPE change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hospital admission rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 24-h postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of PITC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum creatinine level at hospital discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 18F-FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Estimated CV risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: task performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: contextual performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: absorption
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decrease in [d(31)]palmitate oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maintenance of fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Beck Depression Inventory (BDI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9-year cumulative survival rate
Endpoint domain: Mortality/survival
Primary endpoint: soft and hard tissue peri-implant parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aesthetic parameters (keratinized mucosa width, crown emergence profile, patient satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cefotaxime dosage criteria compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in disability (RMDQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: time to fall asleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First pass success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective anatomic cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in estimated glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline in YMRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in tracer uptake during stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: u-NGAL excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: u-KIM-1 excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of referrals to the COTiD program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Walking performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-km running performance enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-analysable tests rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of advanced neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rates of proximal femoral stress shielding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to complete procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: path length during procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of movements during procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Colony forming unit/mL counts from urine cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Remission rate (LSAS score <30)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LSAS severity drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (LSAS score <50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: evolution of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of remitters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: condom-protected intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemostatic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Biochemical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to tolerance of regular diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of postoperative hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hazard ratio for primary outcome
Endpoint domain: Mortality/survival
Primary endpoint: Hazard ratio for treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: tissue core procurement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bodily pain component score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Risk of institutionalization
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Bioequivalence of paroxetine formulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency after angioplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean DAP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiological outcomes
Primary endpoint: mean AK reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Radiological outcomes
Primary endpoint: maximum amount willing to pay for one drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of drinks consumed if free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mesh exposures
Endpoint domain: Adverse events/effects
Primary endpoint: relaxation effects of wine
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sexuality effects of wine
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: impairing effects of wine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MUC1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MUC4 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MUC5AC expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MUC5B expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height Standard Deviation Score (HSDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sitting height Standard Deviation Score (SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-frequency power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vagal tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RBCF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Five-year recurrence-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Five-year progression-free survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Mean exercise induced fall in FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Activity limitation domain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pulmonary function (FEV1 and FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-prandial glycaemia at 120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Control of target symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean child weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cumulative incidence of underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of new morphometric vertebral fracture
Endpoint domain: Mortality/survival
Primary endpoint: serum UA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WMH volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) for back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Response rate to stimulants for ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lateral weight shifting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight bearing through affected leg after weight shifted to the affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported eating disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety about sexual and romantic relationships
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: body image
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning